Replimune announces $125M offering after FDA submission for RP1; Otsuka partners with Ionis on ALS drug ulefnersen; Kanglin Biotechnology raises $20M; Seelos files bankruptcy; Orbus reports positive ...
Gilead acquires HTI T-cell immunogen HIV vaccines from Barcelona's Aelix Therapeutics for an undisclosed amount. The vaccines ...
After recently discontinuing R&D for Truqap in triple-negative breast cancer, AstraZeneca has some good news on its kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback